Search

Your search keyword '"Kaneyasu, Yuko"' showing total 158 results
Start Over Author "Kaneyasu, Yuko"
158 results on '"Kaneyasu, Yuko"'

1. Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study

Author

Yoshida, Masahiro, Yoshimura, Ryo-ichi, Notake, Ryoichi, Shinjo, Hidenori, Miyaura, Kazunori, Kuwayama, Takashi, Kawanaka, Takashi, Shien, Tadahiko, Yoshio, Kotaro, Shiga, Toshiko, Kaneyasu, Yuko, Nakagawa, Tsuyoshi, Kubota, Kazunori, Nakamura, Seigo, and Itami, Jun

Published
2024
Full Text
View/download PDF

3. Why not de-intensification for uterine cervical cancer?

Author

Murakami, Naoya, Ando, Ken, Murata, Masumi, Murata, Kazutoshi, Ohno, Tatsuya, Aoshika, Tomomi, Kato, Shingo, Okonogi, Noriyuki, Saito, Anneyuko I., Kim, Joo-Young, Kumai, Yasuko, Yoshioka, Yasuo, Sekii, Shuhei, Tsujino, Kayoko, Lowanichkiattikul, Chairat, Pattaranutaporn, Poompis, Kaneyasu, Yuko, Nakagawa, Tomio, Watanabe, Miho, Uno, Takashi, Umezawa, Rei, Jingu, Keiichi, Kanemoto, Ayae, Wakatsuki, Masaru, Shirai, Katsuyuki, Igaki, Hiroshi, and Itami, Jun

Published
2021
Full Text
View/download PDF

5. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma

Author

Murakami, Naoya, Ando, Ken, Murata, Masumi, Murata, Kazutoshi, Ohno, Tatsuya, Aoshika, Tomomi, Kato, Shingo, Okonogi, Noriyuki, I Saito, Anneyuko, Joo-Young, Kim, Yoshioka, Yasuo, Sekii, Shuhei, Tsujino, Kayoko, Lowanichkiattikul, Chairat, Pattaranutaporn, Poompis, Kaneyasu, Yuko, Nakagawa, Tomio, Watanabe, Miho, Uno, Takashi, Umezawa, Rei, Jingu, Keiichi, Kanemoto, Ayae, Wakatsuki, Masaru, Shirai, Katsuyuki, Igaki, Hiroshi, Itami, Jun, Ken, Ando, Kazutoshi, Murata, Tatsuya, Ohno, Shingo, Kato, Noriyuki, Okonogi, Takashi, Uno, Keiichi, Jingu, Masaru, Wakatsuki, Katsuyuki, Shirai, and Jun, Itami

Abstract

This study is an international multi-institutional retrospective study comparing the clinical outcomes between intracavitary brachytherapy (ICBT) and the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients treated with definitive radiation therapy. Locally advanced cervical cancer, the initial size of which is larger than 4cm and treated by concurrent chemoradiotherapy and image-guided adaptive brachytherapy, were eligible for this retrospective study. Patients who received HBT at least once were included in the HBT group, and patients who received only ICBT were included in the ICBT group. Anonymized data from 469 patients from 13 institutions in Japan, one from Korea and one from Thailand, were analyzed. Two hundred eighty and 189 patients were included in the ICBT group and the HBT group, respectively. Patients in the HBT group had more advanced stage, non-Scc histopathology, a higher rate of uterine body involvement, larger tumor at diagnosis, larger tumor before brachytherapy and a lower tumor reduction ratio. With a median follow-up of 51.3months (2.1-139.9months), 4-y local control (LC), progression-free survival (PFS) and overall survival (OS) for the entire patient population were 88.2%, 64.2% and 83%, respectively. The HBT group received a higher HR-CTV D90 than that of the ICBT group (68.8Gy vs 65.6Gy, P = 0.001). In multivariate analysis, the non-Scc histological subtype, HR-CTV D95 ≤ 60Gy, reduction ratio ≤ 29% and total treatment time (TTT) ≥ 9weeks were identified as the independent adverse prognostic factors for LC. Regarding LC, no difference was found between ICBT and HBT (4-y LC 89.3% vs 86.8%, P = 0.314). After adjustment for confounding factors by propensity score matching, no advantage of applying HBT was demonstrated regarding LC, PFS, or OS. Despite the fact that HBT patients had more adverse clinical factors than ICBT patients, HBT delivered a higher dose to HR-CTV and resulted in comparable LC.

Published
2022

6. Data from IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis

Author

Isomura, Minoru, primary, Oya, Natsuo, primary, Tachiiri, Seiji, primary, Kaneyasu, Yuko, primary, Nishimura, Yasumasa, primary, Akimoto, Tetsuo, primary, Hareyama, Masato, primary, Sugita, Tadasi, primary, Mitsuhashi, Norio, primary, Yamashita, Takashi, primary, Aoki, Masahiko, primary, Sai, Heitetsu, primary, Hirokawa, Yutaka, primary, Sakata, Koh-ichi, primary, Karasawa, Kumiko, primary, Tomida, Akihiro, primary, Tsuruo, Takashi, primary, Miki, Yoshio, primary, Noda, Tetsuo, primary, and Hiraoka, Masahiro, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table S2 from IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis

Author

Isomura, Minoru, primary, Oya, Natsuo, primary, Tachiiri, Seiji, primary, Kaneyasu, Yuko, primary, Nishimura, Yasumasa, primary, Akimoto, Tetsuo, primary, Hareyama, Masato, primary, Sugita, Tadasi, primary, Mitsuhashi, Norio, primary, Yamashita, Takashi, primary, Aoki, Masahiko, primary, Sai, Heitetsu, primary, Hirokawa, Yutaka, primary, Sakata, Koh-ichi, primary, Karasawa, Kumiko, primary, Tomida, Akihiro, primary, Tsuruo, Takashi, primary, Miki, Yoshio, primary, Noda, Tetsuo, primary, and Hiraoka, Masahiro, primary

Published
2023
Full Text
View/download PDF

8. Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer

Author

Murakami, Naoya, primary, Watanabe, Miho, additional, Uno, Takashi, additional, Sekii, Shuhei, additional, Tsujino, Kayoko, additional, Kasamatsu, Takahiro, additional, Machitori, Yumiko, additional, Aoshika, Tomomi, additional, Kato, Shingo, additional, Hirowatari, Hisako, additional, Kaneyasu, Yuko, additional, Nakagawa, Tomio, additional, Ikushima, Hitoshi, additional, Ando, Ken, additional, Murata, Masumi, additional, Yoshida, Ken, additional, Yoshioka, Hiroto, additional, Murata, Kazutoshi, additional, Ohno, Tatsuya, additional, Okonogi, Noriyuki, additional, Saito, Anneyuko I., additional, Ichikawa, Mayumi, additional, Okuda, Takahito, additional, Tsuchida, Keisuke, additional, Sakurai, Hideyuki, additional, Yoshimura, Ryoichi, additional, Yoshioka, Yasuo, additional, Yorozu, Atsunori, additional, Kunitake, Naonobu, additional, Okamoto, Hiroyuki, additional, Inaba, Koji, additional, Kato, Tomoyasu, additional, Igaki, Hiroshi, additional, and Itami, Jun, additional

Published
2023
Full Text
View/download PDF

11. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial

Author

Murakami, Naoya, primary, Watanabe, Miho, additional, Uno, Takashi, additional, Sekii, Shuhei, additional, Tsujino, Kayoko, additional, Kasamatsu, Takahiro, additional, Machitori, Yumiko, additional, Aoshika, Tomomi, additional, Kato, Shingo, additional, Hirowatari, Hisako, additional, Kaneyasu, Yuko, additional, Nakagawa, Tomio, additional, Ikushima, Hitoshi, additional, Ando, Ken, additional, Murata, Masumi, additional, Yoshida, Ken, additional, Yoshioka, Hiroto, additional, Murata, Kazutoshi, additional, Ohno, Tatsuya, additional, Okonogi, Noriyuki, additional, Saito, Anneyuko, additional, Ichikawa, Mayumi, additional, Okuda, Takahito, additional, Tsuchida, Keisuke, additional, Sakurai, Hideyuki, additional, Yoshimura, Ryouichi, additional, Yoshioka, Yasuo, additional, Yorozu, Atsunori, additional, Okamoto, Horoyuki, additional, Inaba, Koji, additional, Kato, Tomoyasu, additional, Igaki, Hiroshi, additional, and Itami, Jun, additional

Published
2022
Full Text
View/download PDF

14. An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma

Author

Okonogi, Noriyuki, primary, Murakami, Naoya, additional, Ando, Ken, additional, Murata, Masumi, additional, Murata, Kazutoshi, additional, Aoshika, Tomomi, additional, Kato, Shingo, additional, I Saito, Anneyuko, additional, Kim, Joo-Young, additional, Yoshioka, Yasuo, additional, Sekii, Shuhei, additional, Tsujino, Kayoko, additional, Lowanichkiattikul, Chairat, additional, Pattaranutaporn, Poompis, additional, Kaneyasu, Yuko, additional, Nakagawa, Tomio, additional, Watanabe, Miho, additional, Uno, Takashi, additional, Umezawa, Rei, additional, Jingu, Keiichi, additional, Kanemoto, Ayae, additional, Wakatsuki, Masaru, additional, Shirai, Katsuyuki, additional, Igaki, Hiroshi, additional, Ohno, Tatsuya, additional, and Itami, Jun, additional

Published
2022
Full Text
View/download PDF

16. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group

Author

Ikushima, Hitoshi, primary, Haga, Akihiro, additional, Ando, Ken, additional, Kato, Shingo, additional, Kaneyasu, Yuko, additional, Uno, Takashi, additional, Okonogi, Noriyuki, additional, Yoshida, Kenji, additional, Ariga, Takuro, additional, Isohashi, Fumiaki, additional, Harima, Yoko, additional, Kanemoto, Ayae, additional, Ii, Noriko, additional, Wakatsuki, Masaru, additional, and Ohno, Tatsuya, additional

Published
2021
Full Text
View/download PDF

17. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study

Author

Harima, Yoko, primary, Ariga, Takuro, additional, Kaneyasu, Yuko, additional, Ikushima, Hitoshi, additional, Tokumaru, Sunao, additional, Shimamoto, Shigetoshi, additional, Takahashi, Takeo, additional, Ii, Noriko, additional, Tsujino, Kayoko, additional, Saito, Anneyuko I., additional, Ushijima, Hiroki, additional, Toita, Takafumi, additional, and Ohno, Tatsuya, additional

Published
2021
Full Text
View/download PDF

22. Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.

Author

Murakami, Naoya, Ando, Ken, Murata, Masumi, Murata, Kazutoshi, Ohno, Tatsuya, Aoshika, Tomomi, Kato, Shingo, Okonogi, Noriyuki, Saito, Anneyuko I, Kim, Joo-Young, Yoshioka, Yasuo, Sekii, Shuhei, Tsujino, Kayoko, Lowanichkiattikul, Chairat, Pattaranutaporn, Poompis, Kaneyasu, Yuko, Nakagawa, Tomio, Watanabe, Miho, Uno, Takashi, and Umezawa, Rei

Subjects
RADIOISOTOPE brachytherapy, INTERSTITIAL brachytherapy, PROPENSITY score matching, PROGRESSION-free survival, RETROSPECTIVE studies, PROGNOSIS
Abstract

This study is an international multi-institutional retrospective study comparing the clinical outcomes between intracavitary brachytherapy (ICBT) and the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients treated with definitive radiation therapy. Locally advanced cervical cancer, the initial size of which is larger than 4 cm and treated by concurrent chemoradiotherapy and image-guided adaptive brachytherapy, were eligible for this retrospective study. Patients who received HBT at least once were included in the HBT group, and patients who received only ICBT were included in the ICBT group. Anonymized data from 469 patients from 13 institutions in Japan, one from Korea and one from Thailand, were analyzed. Two hundred eighty and 189 patients were included in the ICBT group and the HBT group, respectively. Patients in the HBT group had more advanced stage, non-Scc histopathology, a higher rate of uterine body involvement, larger tumor at diagnosis, larger tumor before brachytherapy and a lower tumor reduction ratio. With a median follow-up of 51.3 months (2.1–139.9 months), 4-y local control (LC), progression-free survival (PFS) and overall survival (OS) for the entire patient population were 88.2%, 64.2% and 83%, respectively. The HBT group received a higher HR-CTV D90 than that of the ICBT group (68.8 Gy vs 65.6 Gy, P  = 0.001). In multivariate analysis, the non-Scc histological subtype, HR-CTV D95 ≤ 60 Gy, reduction ratio ≤ 29% and total treatment time (TTT) ≥ 9 weeks were identified as the independent adverse prognostic factors for LC. Regarding LC, no difference was found between ICBT and HBT (4-y LC 89.3% vs 86.8%, P  = 0.314). After adjustment for confounding factors by propensity score matching, no advantage of applying HBT was demonstrated regarding LC, PFS, or OS. Despite the fact that HBT patients had more adverse clinical factors than ICBT patients, HBT delivered a higher dose to HR-CTV and resulted in comparable LC. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

25. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.

Author

Ikushima, Hitoshi, Haga, Akihiro, Ando, Ken, Kato, Shingo, Kaneyasu, Yuko, Uno, Takashi, Okonogi, Noriyuki, Yoshida, Kenji, Ariga, Takuro, Isohashi, Fumiaki, Harima, Yoko, Kanemoto, Ayae, Ii, Noriko, Wakatsuki, Masaru, and Ohno, Tatsuya

Subjects
CERVICAL cancer, MAGNETIC resonance imaging, CHEMORADIOTHERAPY
Abstract

We retrospectively assessed whether magnetic resonance imaging (MRI) radiomics combined with clinical parameters can improve the predictability of out-of-field recurrence (OFR) of cervical cancer after chemoradiotherapy. The data set was collected from 204 patients with stage IIB (FIGO: International Federation of Gynecology and Obstetrics 2008) cervical cancer who underwent chemoradiotherapy at 14 Japanese institutes. Of these, 180 patients were finally included for analysis. OFR-free survival was calculated using the Kaplan–Meier method, and the statistical significance of clinicopathological parameters for the OFR-free survival was evaluated using the log-rank test and Cox proportional-hazards model. Prediction of OFR from the analysis of diffusion-weighted images (DWI) and T2-weighted images of pretreatment MRI was done using the least absolute shrinkage and selection operator (LASSO) model for engineering image feature extraction. The accuracy of prediction was evaluated by 5-fold cross-validation of the receiver operating characteristic (ROC) analysis. Para-aortic lymph node metastasis (p  = 0.003) was a significant prognostic factor in univariate and multivariate analyses. ROC analysis showed an area under the curve (AUC) of 0.709 in predicting OFR using the pretreatment status of para-aortic lymph node metastasis, 0.667 using the LASSO model for DWIs and 0.602 using T2 weighted images. The AUC improved to 0.734 upon combining the pretreatment status of para-aortic lymph node metastasis with that from the LASSO model for DWIs. Combining MRI radiomics with clinical parameters improved the accuracy of predicting OFR after chemoradiotherapy for locally advanced cervical cancer. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

30. Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum

Author

Kaneyasu, Yuko, primary, Koh, Iemasa, additional, Fujiwara, Hisaya, additional, Hirata, Eiji, additional, Kudo, Yoshiki, additional, Arihiro, Koji, additional, Miharu, Norio, additional, Nakagawa, Tomio, additional, Takahashi, Ippei, additional, Takeuchi, Yuki, additional, Imano, Nobuki, additional, Nishibuchi, Ikuno, additional, Nakashima, Takeo, additional, Kawahara, Daisuke, additional, Ohno, Yoshimi, additional, and Nagata, Yasushi, additional

Published
2019
Full Text
View/download PDF

31. A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.

Author

Kaneyasu, Yuko, Fujiwara, Hisaya, Nishimura, Tetsuo, Sakurai, Hideyuki, Kazumoto, Tomoko, Ikushima, Hitoshi, Uno, Takashi, Tokumaru, Sunao, Harima, Yoko, Gomi, Hiromichi, Toita, Takafumi, Kita, Midori, Noda, Shin-ei, Takahashi, Takeo, Kato, Shingo, Ohkawa, Ayako, Tozawa-Ono, Akiko, Ushijima, Hiroki, Hasumi, Yoko, and Hirashima, Yasuyuki

Subjects
QUALITY of life, CERVICAL cancer, RADIOTHERAPY
Abstract

This study aimed to research the post-treatment quality of life (QOL) between radiotherapy (RT)- and operation (OP)-treated early cervical cancer survivors, using separate questionnaires for physicians and patients. We administered an observational questionnaire to patients aged 20–70 years old with Stages IB1–IIB cervical cancer who had undergone RT or OP and without recurrence as outpatients for ≥6 months after treatment. We divided 100 registered patients equally into two treatment groups (n  = 50 each). The average age was 53 and 44 years in the RT and OP groups, respectively. The RT group included 34 and 66% Stage I and II patients, respectively, whereas the OP group included 66 and 34% Stage I and II patients, respectively. The OP group included 58% of patients with postoperative RT. Combination chemotherapy was performed in 84 and 48% of patients in the RT and OP groups, respectively. On the physicians' questionnaire, we observed significant differences in bone marrow suppression (RT) and leg edema (OP). On the patients' questionnaire, significantly more patients had dysuria and leg edema in the OP group than in the RT group, and severe (Score 4–5) leg edema was significantly higher in the post-operative RT group than in the OP only group. The frequency of sexual intercourse decreased after treatment in both groups. On the patients' questionnaire, there were no significant differences between the two groups regarding sexual activity. These findings are useful to patients and physicians for shared decision-making in treatment choices. The guidance of everyday life and health information including sexual life after treatment is important. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

33. Six-year Experience of Permanent Prostate Brachytherapy for Clinically Localized Prostate Cancer

Author

Teishima, Jun, Kenjo, Masahiro, Kobatake, Kohei, Iwamoto, Hideo, Goriki, Akihiro, Oki, Mami, Shoji, Koichi, Miyamoto, Katsutoshi, Masumoto, Hiroshi, Inoue, Shogo, Kobayashi, Kanao, Ohara, Shinya, Kajiwara, Mitsuru, Kimura, Tomoki, Murakami, Yuji, Kaneyasu, Yuko, Nishibuchi, Ikuno, Nagata, Yasushi, and Matsubara, Akio

Subjects
Localized prostate cancer, Brachytherapy, Iodine-125 seed
Abstract

This report presents the outcome of prostate permanent brachytherapy (PPB). One hundred and seventy-two patients with clinically localized prostate cancer were treated with permanent brachytherapy using iodine-125 seeds (125-I) at Hiroshima University Hospital from July 2004 to June 2010. This study evaluated the efficacy of PPB in these patients. The median patient age was 69 years (range 53 to 82 years), the median prostate-specific antigen (PSA) value before biopsy was 6.75 ng/ml (range 3.5 to 47.9 ng/ml), and the median prostate volume was 23.1 ml (range 10.1 to 57 ml). The median follow-up was 37 months (range 1 to 72 months). The serum PSA levels decreased continuously after PPB throughout the entire follow-up period in 97% of patients without neoadjuvant hormonal therapy. No relapse occurred during the follow-up period in patients at low risk. Our 6-year experience suggests that PPB is effective for localized prostate cancer. Patients with prostate cancer that does not require combined External beam radiation therapy (EBRT) have the best chance of responding to treatment.

Published
2011

34. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study

Author

Ariga, Takuro, primary, Toita, Takafumi, additional, Kato, Shingo, additional, Kazumoto, Tomoko, additional, Kubozono, Masaki, additional, Tokumaru, Sunao, additional, Eto, Hidehiro, additional, Nishimura, Tetsuo, additional, Niibe, Yuzuru, additional, Nakata, Kensei, additional, Kaneyasu, Yuko, additional, Nonoshita, Takeshi, additional, Uno, Takashi, additional, Ohno, Tatsuya, additional, Iwata, Hiromitsu, additional, Harima, Yoko, additional, Wada, Hitoshi, additional, Yoshida, Kenji, additional, Gomi, Hiromichi, additional, Numasaki, Hodaka, additional, Teshima, Teruki, additional, Yamada, Shogo, additional, and Nakano, Takashi, additional

Published
2015
Full Text
View/download PDF

36. In Reply to Coza

Author

Kaneyasu, Yuko, primary, Kita, Midori, additional, Okawa, Tomohiko, additional, Maebayashi, Katsuya, additional, Kohno, Mari, additional, Sonoda, Tatsuo, additional, Hirabayashi, Hisae, additional, Nagata, Yasushi, additional, and Mitsuhashi, Norio, additional

Published
2013
Full Text
View/download PDF

38. Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients.

Author

Ohno, Tatsuya, Wakatsuki, Masaru, Toita, Takafumi, Kaneyasu, Yuko, Yoshida, Ken, Kato, Shingo, Ii, Noriko, Tokumaru, Sunao, Ikushima, Hitoshi, Uno, Takashi, Noda, Shin-Ei, Kazumoto, Tomoko, and Harima, Yoko

Abstract

Our purpose was to develop recommendations for contouring the computed tomography (CT)-based high-risk clinical target volume (CTVHR) for 3D image-guided brachytherapy (3D-IGBT) for cervical cancer. A 15-member Japanese Radiation Oncology Study Group (JROSG) committee with expertise in gynecological radiation oncology initiated guideline development for CT-based CTVHR (based on a comprehensive literature review as well as clinical experience) in July 2014. Extensive discussions occurred during four face-to-face meetings and frequent email communication until a consensus was reached. The CT-based CTVHR boundaries were defined by each anatomical plane (cranial-caudal, lateral, or anterior-posterior) with or without tumor progression beyond the uterine cervix at diagnosis. Since the availability of magnetic resonance imaging (MRI) with applicator insertion for 3D planning is currently limited, T2-weighted MRI obtained at diagnosis and just before brachytherapy without applicator insertion was used as a reference for accurately estimating the tumor size and topography. Furthermore, utilizing information from clinical examinations performed both at diagnosis and brachytherapy is strongly recommended. In conclusion, these recommendations will serve as a brachytherapy protocol to be used at institutions with limited availability of MRI for 3D treatment planning.

Published
2017
Full Text
View/download PDF

40. A Survey of Patients with Inflammatory Skin Recurrence Corresponding to the Area of Previous Irradiation after Postoperative Radiotherapy for Breast Cancer

Author

TSUJINO, Kayoko, primary, KASHIHARA, Kenichi, additional, KOTANI, Shouko, additional, HAYAKAWA, Kazushige, additional, IMANAKA, Kazufumi, additional, TAKADA, Yasuhiro, additional, UNO, Takashi, additional, HIRATA, Hideki, additional, KANEYASU, Yuko, additional, SEKIGUCHI, Kenji, additional, OGO, Etsuyo, additional, HIRATSUKA, Junichi, additional, YODEN, Eisaku, additional, and SOEJIMA, Toshinori, additional

Published
2011
Full Text
View/download PDF

41. IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis

Author

Isomura, Minoru, primary, Oya, Natsuo, additional, Tachiiri, Seiji, additional, Kaneyasu, Yuko, additional, Nishimura, Yasumasa, additional, Akimoto, Tetsuo, additional, Hareyama, Masato, additional, Sugita, Tadasi, additional, Mitsuhashi, Norio, additional, Yamashita, Takashi, additional, Aoki, Masahiko, additional, Sai, Heitetsu, additional, Hirokawa, Yutaka, additional, Sakata, Koh-ichi, additional, Karasawa, Kumiko, additional, Tomida, Akihiro, additional, Tsuruo, Takashi, additional, Miki, Yoshio, additional, Noda, Tetsuo, additional, and Hiraoka, Masahiro, additional

Published
2008
Full Text
View/download PDF

43. Evaluation of a Worksheet for Monitoring Adverse Reactions during Concurrent Chemoradiation

Author

Shibata, Yuuka, primary, Ikeda, Hiroaki, additional, Fujiwara, Hisaya, additional, Kaneyasu, Yuko, additional, Yunokawa, Mayu, additional, Itakura, Yukari, additional, Isobe, Kazumi, additional, Saeki, Yasuyuki, additional, Izumitani, Satoru, additional, Unei, Hiroko, additional, Nishihara, Masayuki, additional, Kudo, Yosiki, additional, and Kihira, Kenji, additional

Published
2007
Full Text
View/download PDF

44. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers?

Author

Kimura, Tomoki, primary, Matsuura, Kanji, additional, Murakami, Yuji, additional, Hashimoto, Yasutoshi, additional, Kenjo, Masahiro, additional, Kaneyasu, Yuko, additional, Wadasaki, Koichi, additional, Hirokawa, Yutaka, additional, Ito, Katsuhide, additional, and Okawa, Motoomi, additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results